Dr_Raoul_Wadoum_Microbiology_SCS_Note_2024.pdf

KamaraJohnS 0 views 24 slides Sep 30, 2025
Slide 1
Slide 1 of 24
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24

About This Presentation

A good Microbiology presentation


Slide Content

1

MEDICAL MICROBIOLOGY AND IMMUNOLOGY
Lecturer: Dr. Raoul Emeric Guetiya Wadoum BSc, MSc, PhD, MPH, MCG-GM

COURSE DESCRIPTION:
This course is designed for medical students, nurses, clinical assistants, and medical doctors. It
provides a comprehensive understanding of the microbes that cause diseases in humans, the
immune responses they invoke, and methods of prevention, control, and treatment.

COURSE OBJECTIVES:
By the end of the course, students should be able to:
1. Describe the basic structure and biology of various microorganisms.
2. Recognize the pathogens most frequently responsible for diseases in humans.
3. Understand the mechanisms of pathogenesis and immune responses.
4. Identify standard methods for the diagnosis, treatment, and prevention of microbial
diseases.
5. Understand principles of infection prevention, control, and prophylaxis in a clinical
setting and Nosocomial Infections.
6. Understand principles of Post-Exposure Prophylaxis
7. Understand the principles of Pre-Exposure Prophylaxis
8. Recognize the importance of Immune System, Vaccines, Immunization

2



CHAPTER 1 – INTRODUCTION TO MEDICAL
MICROBIOLOGY

1.1. History and Scope
Overview
Medical Microbiology is a branch of medicine concerned with the prevention, diagnosis, and treatment
of infectious diseases. It also includes the study of beneficial microorganisms that exist and affect our
lives.

1.2. The Impact of Medical Microbiology
This field has revolutionized medicine, contributing significantly to understanding human diseases and
developing treatments. It plays a vital role in areas like infection control, epidemiology, and vaccine
development.

1.3. Key Milestones
 The invention of the Microscope: Pioneered by Anton van Leeuwenhoek in the 17th century,
the microscope opened a new world of microorganisms, changing our understanding of biology.

 Discovery of Germ Theory: Proposed by Louis Pasteur and Robert Koch, this theory established
that microorganisms cause diseases, leading to improved sanitation and food safety practices.


 Development of Vaccines and Antibiotics: Milestones like Edward Jenner's smallpox vaccine
and Alexander Fleming's discovery of penicillin have been critical in combating infectious
diseases.

3

2. Classification and Taxonomy of Microorganisms

2.1. Basics of Microbial Classification
Microorganisms are classified based on characteristics such as:
 Shape: Rod-shaped (bacilli), spherical (cocci), or spiral (spirilla).

 Oxygen Requirement: Aerobic (requires oxygen) or anaerobic (does not require oxygen).

 Staining Properties: Gram-positive (retain crystal violet stain) or Gram-negative (do not retain
it).

2.2. Major Groups of Microorganisms

 Bacteria: Unicellular organisms, e.g., E. coli (a gut bacterium), and Streptococcus (causes sore
throat).

 Viruses: Non-cellular entities that can only replicate inside a host cell, e.g., HIV, influenza.

 Fungi: Ranging from single-celled yeasts to multicellular molds, e.g., Candida albicans.

 Protozoa: Single-celled, often parasitic organisms, e.g., Plasmodium falciparum (causes
malaria).

 Algae: Primarily aquatic organisms, important for ecosystems and can be used in biofuel
production.

3. Normal Flora vs Pathogens

3.1. Understanding Normal Flora
Normal flora are microorganisms that reside in and on our bodies, playing a crucial role in digestion,
nutrient absorption, and immunity. They can also prevent colonization by harmful pathogens.

3.2. Pathogens and Disease
Pathogens are harmful microorganisms that can cause diseases. They invade the body, evade the
immune system, and can produce toxins.

4

3.3. Comparative Analysis

3.4. Images of Microorganisms
Visual representations of bacteria, viruses, fungi, protozoa, and algae, illustrating their diversity.

5

4. Case Study
Discuss real-life cases where understanding microbiology led to significant medical breakthroughs or
solved complex medical cases.
Below is a guide for discussion, highlighting key cases and the microbiological principles involved:
Example 1. Discovery of Penicillin
 Background: Discovered by Alexander Fleming in 1928, penicillin became the first true antibiotic.
Discussion Points:
 The accidental discovery of a mold (Penicillium notatum).
 Its revolutionary impact on treating bacterial infections, especially during WWII.
 The role of microbiology in understanding antibiotic production and action.
Example 2. Eradication of Smallpox
 Background: Smallpox, caused by the Variola virus, was eradicated in 1980 through a global
vaccination campaign.
Discussion Points:
 The development of the smallpox vaccine by Edward Jenner using cowpox virus.
 The global vaccination strategy and the role of epidemiology.
 The significance of virus characterization in vaccine development.
Example 3. Identification and Containment of HIV/AIDS
 Background: HIV was identified in the early 1980s as the cause of AIDS.
Discussion Points:
 The discovery process of HIV as a new virus.
 Development of antiretroviral therapy (ART) to manage HIV infection.
 The importance of understanding viral replication and mutation in developing treatments.

Example 4. H. pylori and Peptic Ulcer Disease
 Background: The discovery that Helicobacter pylori bacteria cause peptic ulcers revolutionized its
treatment.
Discussion Points:
 Overturning the misconception that ulcers were caused by stress or spicy food.
 The role of bacterial culture and identification in linking H. pylori to ulcers.
 The impact on treatment, shifting from acid reduction to antibiotic therapy.

Example 5. COVID-19 Pandemic and Vaccine Development

6

 Background: The rapid development of vaccines against SARS-CoV-2.
Discussion Points:
 The role of genomic sequencing in rapidly identifying the virus.
 mRNA vaccine technology and its development.
 Global immunization efforts and challenges in vaccine distribution.
Example 6. Cystic Fibrosis and Microbial Infections
 Background: Understanding the role of specific bacterial infections in cystic fibrosis patients.
Discussion Points:
 How chronic Pseudomonas aeruginosa infections affect cystic fibrosis patients.
 Development of targeted antibiotic therapies.
 The role of microbiome studies in understanding disease progression.

Guidelines for the Discussion:
A. Provide Context: Start each case with a brief background to set the stage.
B. Focus on Microbiology: Highlight how microbiological knowledge was crucial in each case.
C. Encourage Interaction: Ask open-ended questions to engage participants.
D. Link to Current Research: Where applicable, link these cases to ongoing research and current
challenges.
E. Discuss Ethical and Social Implications: Where relevant, discuss the broader impact of these
breakthroughs on society and ethics.

7


Figure 2: Image of a microscope.

8


CHAPTER II – BACTERIOLOGY
1. Structure and Function of Bacterial Cells: Bacteria are prokaryotic organisms with a simple cellular structure.
Key components include the cell wall, plasma membrane, ribosomes, and genetic material (DNA).
2.


2. Mechanisms of Bacterial Pathogenesis: Pathogenic bacteria cause disease through mechanisms such as
producing toxins, adhering to host cells, and evading the immune system.
3. Laboratory Diagnosis, Treatment, and Prevention of Bacterial Diseases: Diagnosis often involves culturing and
microscopic examination. Antibiotics are the mainstay of treatment, while prevention includes vaccination and
hygiene practices.

9

4. Common Bacterial Diseases:
 Tuberculosis (Mycobacterium tuberculosis)
 Staphylococcal Infections (Staphylococcus aureus)
 Streptococcal Throat Infections (Streptococcus pyogenes)
 Salmonellosis (Salmonella species)
 Cholera (Vibrio cholerae)
 Gonorrhea (Neisseria gonorrhoeae)
 Pneumonia (Streptococcus pneumoniae)
 Lyme Disease (Borrelia burgdorferi)
 Tetanus (Clostridium tetani)
 Diphtheria (Corynebacterium diphtheriae)

5. Case Study for Bacteriology:
Case Study: A 25-year-old male presents with a persistent cough, night sweats, and weight loss. A chest X-ray
shows lung infiltrates and a sputum test is positive for acid-fast bacilli.
Questions:
a. What is the most likely diagnosis?
b. What are the key features of the causative agent's structure?
c. Which treatment regimen is appropriate for this condition?
d. How can this disease be prevented in a healthcare setting?

Answers:
a. Tuberculosis.
b. Mycobacterium tuberculosis is a rod-shaped bacterium with a waxy cell wall, making it acid-fast.
c. A combination of antibiotics such as isoniazid and rifampicin for at least 6 months.
d. Use of personal protective equipment, isolation of the patient, and BCG vaccination.

10

CHAPTER III – VIROLOGY
1. General Properties of Viruses: Viruses are microscopic infectious agents that can only replicate inside a host's
cells. They consist of genetic material (DNA or RNA) surrounded by a protein coat.


2. Mechanisms of Viral Infections and Pathogenesis: Viruses enter host cells and hijack their machinery to produce
new viral particles. Pathogenesis varies depending on the virus, ranging from mild infections to severe diseases.
3. Laboratory Diagnosis, Treatment, and Prevention of Viral Diseases: Diagnosis often involves PCR and serology
tests. Antiviral drugs and supportive care are used for treatment. Vaccination is key for prevention.

11

4. Common Viral Diseases:
 Influenza (Influenza virus)
 HIV/AIDS (Human Immunodeficiency Virus)
 Hepatitis B and C (Hepatitis B virus, Hepatitis C virus)
 Herpes Simplex (Herpes Simplex Virus)
 Varicella (Varicella-Zoster Virus)
 Human Papillomavirus Infection (HPV)
 Rabies (Rabies Virus)
 Dengue Fever (Dengue Virus)
 Ebola Virus Disease (Ebola Virus)
 COVID-19 (SARS-CoV-2)

5. Case Study for Virology:
A 32-year-old woman presents with fever, severe headache, and a rash. She recently returned from a trip to
a tropical country.
Questions:
a. What is the likely viral infection?
b. What are general properties of the suspected virus?
c. What treatment should be administered?
d. What preventive measures could have been taken?
Answers:
a. Dengue Fever.
b. Dengue Virus is an RNA virus transmitted by mosquitoes.
c. Supportive care as there is no specific antiviral treatment for Dengue.
d. Mosquito control and use of repellents.

12

CHAPTER IV – MYCOLOGY
1. Overview of Medically Significant Fungi: Fungi can be unicellular (yeasts) or multicellular (molds and
mushrooms) and cause a range of infections.


2. Mycoses: Fungal infections can affect the skin, nails, or internal organs. Common mycoses include athlete's
foot, ringworm, and candidiasis.
3. Laboratory Diagnosis, Treatment, and Prevention of Fungal Diseases: Diagnosis often involves microscopic
examination and culture. Treatment includes antifungal medications. Prevention focuses on hygiene and
environmental control.

13

4. Common Fungal Diseases:
 Candidiasis (Candida species)
 Athlete's Foot (Trichophyton species)
 Ringworm (Dermatophytes)
 Aspergillosis (Aspergillus species)
 Cryptococcosis (Cryptococcus neoformans)
 Histoplasmosis (Histoplasma capsulatum)
 Pneumocystis Pneumonia (Pneumocystis jirovecii)
 Blastomycosis (Blastomyces dermatitidis)
 Coccidioidomycosis (Coccidioides species)
 Mucormycosis (Mucorales)

5. Case Study for Mycology:
A patient with HIV/AIDS presents with severe respiratory distress and a CD4 count of 50 cells/μL. A lung
biopsy reveals yeast-like cells.
Questions:
a. What fungal infection is most likely?
b. What is the typical habitat of the causative organism?
c. How should this infection be treated?
d. What could have been done to prevent this condition?

Answers:
a. Pneumocystis Pneumonia.
b. Pneumocystis jirovecii is commonly found in the environment and does not typically affect
healthy individuals.
c. Treatment with high-dose trimethoprim-sulfamethoxazole.
d. Prophylactic administration of trimethoprim-sulfamethoxazole in AIDS patients with low CD4
counts.

14

CHAPTER V – PARASITOLOGY
1. Protozoa and Helminths Causing Human Diseases: These include single-celled organisms like Plasmodium
(malaria) and multicellular worms like tapeworms.

2. Mechanisms of Parasitic Infections and Pathogenesis: Transmission can be via ingestion, skin contact, or
vectors. Parasites can cause damage by feeding on or inside the host.
3. Laboratory Diagnosis, Treatment, and Prevention of Parasitic Diseases: Diagnosis often involves microscopy
and antigen tests. Treatment includes specific antiparasitic medications. Prevention involves sanitation and vector
control.

15

4. Common Parasitic Diseases:
 Malaria (Plasmodium species)
 Schistosomiasis (Schistosoma species)
 Giardiasis (Giardia lamblia)
 Trichomoniasis (Trichomonas vaginalis)
 Hookworm Infection (Ancylostoma duodenale, Necator americanus)
 Filariasis (Wuchereria bancrofti)
 Toxoplasmosis (Toxoplasma gondii)
 Leishmaniasis (Leishmania species)
 Ascariasis (Ascaris lumbricoides)
 Tapeworm Infection (Taenia species)

5. Case Study for Parasitology:
A 10-year-old child presents with abdominal pain, diarrhea, and eosinophilia. He has a history of playing in soil
and sandboxes.
Questions:
a. What is the likely parasitic infection?
b. How is this parasite typically transmitted?
c. What treatment should be considered?
d. What are key preventive strategies?

Answers:
a. Hookworm Infection.
b. Transmission occurs through skin contact with soil contaminated with larval forms of the worm.
c. Anthelmintic medications such as albendazole or mebendazole.
d. Wearing shoes outdoors and improved sanitation practices.

16

CHAPTER VI – IMMUNITY
This chapter introduces the immune system, a complex network vital for defense against infections and diseases.
For nursing students, understanding immunology is key to many therapeutic and preventive healthcare practices.
Section 1: Innate and Adaptive Immunity
1.1 Overview of the Immune System
Definition: The immune system consists of organs, cells, and molecules that protect against pathogens.
Key Components: Skin, mucous membranes, white blood cells, lymph nodes, spleen, thymus, and bone marrow.
1.2 Innate Immunity
First Line of Defense: Includes physical barriers (skin, mucous membranes) and chemical barriers (stomach acid,
enzymes).
Cellular Defenses: Phagocytes (like macrophages and neutrophils) that engulf and destroy pathogens.
Non-Specific Response: Innate immunity targets any pathogen without specificity.
1.3 Adaptive Immunity
Specificity and Memory: Targets specific pathogens and remembers them for quicker response in the future.
Lymphocytes: B-cells (produce antibodies) and T-cells (kill infected cells, assist other immune cells).
Antigen Presentation: Process of displaying antigen fragments on cell surfaces for recognition by T-cells.

17

1.4 Interplay Between Innate and Adaptive Immunity
Cooperation: Innate immunity triggers and shapes the adaptive immune response.
Complement System: A bridge between innate and adaptive immunity, aiding in the destruction of pathogens.
Section 2: Immunological Memory and Vaccination
2.1 Principles of Immunological Memory
Long-Term Protection: Once exposed to a pathogen, the immune system can quickly recognize and combat it
in the future.
Memory Cells: Long-lived B and T cells that remember specific pathogens.
2.2 Mechanism of Vaccines
Simulated Infection: Vaccines introduce an antigen without causing disease, prompting an immune response.
Types of Vaccines: Live attenuated, inactivated, subunit, and mRNA vaccines.
2.3 Role in Public Health
Disease Control: Vaccination programs have controlled or eradicated many infectious diseases.
Herd Immunity: Vaccination helps protect those who cannot be vaccinated by reducing the spread of pathogens.
Section 3: Hypersensitivities, Autoimmunity, and Immunodeficiency
3.1 Hypersensitivities
Types: Classified into four types based on the immune mechanism involved.
Examples: Allergies (Type I), blood transfusion reactions (Type II), immune complex diseases (Type III), and
delayed-type hypersensitivity (Type IV).
3.2 Autoimmunity
Self-Targeting: Immune system mistakenly attacks the body's own cells.

18

Examples: Rheumatoid arthritis, type 1 diabetes, multiple sclerosis.
3.3 Immunodeficiency
Inadequate Immune Response: Either primary (genetic) or acquired (due to disease like HIV/AIDS or drugs).
Consequences: Increased susceptibility to infections and diseases.
Conclusion
The immune system's role in health and disease underlines the importance of immunological knowledge in nursing.
Continuous research is essential for advancing immunological therapies and vaccines.

19

CHAPTER VII – INFECTION PREVENTION AND
CONTROL
1. Overview: Infection Prevention and Control (IPC) is a critical aspect in healthcare settings to prevent the spread
of infections.
2. Hospital-Acquired Infections: These include MRSA, C. difficile, and others. Preventive measures include strict
hygiene practices and isolation protocols.
3. Sterilization and Disinfection: Sterilization kills all forms of microbial life, while disinfection reduces harmful
microorganisms. Methods include heat, chemicals, and radiation.
4. Use of Antiseptics: Antiseptics like alcohols and iodine are used for skin preparation before surgeries and wound
cleaning to prevent infection.
5. Importance: Effective IPC practices protect both patients and healthcare workers from infectious diseases.
Comparison of Disinfectants and Sterilization
Microorganism Disinfectant
Effectiveness
(%)
Sterilization
Effectiveness
(%)
Resistance to
Disinfectants
Resistance to
Sterilization
Bacteria 99% 100% Low Very Low
Viruses 95% 100% Moderate Low
Fungi 98% 100% Low Very Low
Protozoa 90% 100% High Low
Prions N/A Varies High High

Case Study Infection Prevention and Control:
A nurse in a hospital noticed an increasing number of post-operative wound infections over two months.
Investigation revealed inconsistent sterilization practices for surgical instruments.
Questions and Answers:
1. Q: What are the possible consequences of inadequate sterilization?
A: It can lead to hospital-acquired infections and spread of resistant bacteria.

20

2. Q: Name two effective sterilization methods.
A: Autoclaving and Ethylene oxide sterilization.
3. Q: How can the hospital prevent such infections?
A: Implementing strict sterilization protocols and staff training.
4. Q: What role do nurses play in IPC?
A: Maintaining aseptic techniques and monitoring infection control practices.

21

CHAPTER VIII – POST-EXPOSURE PROPHYLAXIS (PEP)
1. Overview: PEP involves taking medication immediately after potential exposure to an infectious agent to prevent
infection.
2. Indications: PEP is used in cases of exposure to HIV, rabies, hepatitis B, and other infectious agents.
3. HIV PEP: Involves a combination of antiretroviral drugs taken for 28 days.
4. Rabies PEP: Includes administration of rabies vaccine and immunoglobulin.
5. Efficacy and Guidelines: PEP is most effective when started promptly, ideally within hours of exposure.
6. Case Study PEP:
A healthcare worker accidentally pricked herself with a needle used on an HIV-positive patient.
Questions and Answers:
1. Q: What immediate steps should be taken after a needlestick injury?
A: Wash the wound, report the incident, and seek medical assessment.
2. Q: What is the rationale for providing PEP?
A: To reduce the risk of HIV transmission from the contaminated needle.
3. Q: Which medications are used for HIV PEP?
A: A combination of antiretroviral drugs.
4. Q: How long should the PEP regimen be continued?
A: PEP should be continued for 28 days.

22

CHAPTER IX – PRE-EXPOSURE PROPHYLAXIS (PrEP)
1. Overview: PrEP is the regular use of medications by people at high risk of acquiring infections like HIV to prevent
infection.
2. HIV PrEP: Involves taking antiretroviral drugs daily or intermittently.
3. Indications: Recommended for individuals at high risk of HIV infection, such as those with HIV-positive partners.
4. Efficacy: PrEP significantly reduces the risk of acquiring HIV when taken consistently.
5. Monitoring and Guidelines: Regular monitoring is essential for efficacy and safety of PrEP.
6. Case Study PrEP:
A 24-year-old individual with an HIV-positive partner seeks advice on reducing HIV infection risk.
Questions and Answers:
1. Q: What is PrEP and its role?
A: PrEP involves taking antiretroviral medication regularly to prevent HIV infection.
2. Q: What medications are used for HIV PrEP?
A: Tenofovir disoproxil fumarate/emtricitabine (TDF/FTC).
3. Q: What are the criteria for initiating PrEP?
A: Being HIV-negative, having an HIV-positive partner, and high-risk behaviors.
4. Q: Describe follow-up for patients on PrEP.
A: Regular HIV testing, renal function tests, and adherence counseling.

23

CHAPTER X – VACCINES AND IMMUNIZATION
1. Principles of Vaccination: Vaccination stimulates the immune system to develop immunity to specific pathogens.
2. Types of Vaccines: Includes live attenuated, inactivated, subunit, and mRNA vaccines.
3. Immunization Schedules: Recommended schedules for different vaccines based on age, health status, and risk
factors.
4. Vaccine Safety and Efficacy: Vaccines undergo rigorous testing for safety and effectiveness before approval for
public use.
5. Role in Public Health: Vaccination is a key tool in controlling and eliminating infectious diseases.
6. Case Study Vaccines:
A school nurse plans a measles immunization drive following a community outbreak.
Questions and Answers:
1. Q: Why is vaccination important for measles control?
A: It stimulates immunity and interrupts disease transmission.
2. Q: What vaccine is used for measles?
A: The MMR vaccine, a live attenuated vaccine.
3. Q: At what age should children receive the measles vaccine?
A: First dose at 12-15 months, second dose at 4-6 years.
4. Q: How does herd immunity contribute to disease control?
A: It provides indirect protection to unvaccinated individuals.

24

REQUIRED TEXTBOOKS:
 Medical Microbiology by Patrick R. Murray; Ken S. Rosenthal; Michael A. Pfaller.
ISBN: 9780323086929, Publication Date: 2012-11-14

 Historical Atlas of Immunology by Julius M. Cruse; Robert E. Lewis. ISBN:
9781842142172, Publication Date: 2005-03-18.

RECOMMENDED RESOURCES:
 CDC Guidelines on Infection Control
 WHO Guidelines on Post-Exposure Prophylaxis